AMRX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Amneal announced FDA approval and launch of lanreotide injectionSep 19, 2026
- Amneal completed its acquisition of Kashiv BioSciences, creating a global biosimilars leaderAug 10, 2026
- Zambon and Amneal received a positive CHMP opinion for Hopledo in Parkinson's diseaseJun 29, 2026
- Amneal received U.S. FDA approval for Romidepsin Injection SolutionJun 4, 2026
- Amneal reported additional positive interim Phase 4 ELEVATE-PD results for CREXONT in Parkinson’s disease with over 3 extra hours of daily good on timeApr 20, 2026